IntraBiotics Pharmaceuticals Report issue

For profit Phase 3
Founded: Lafayette CA United States (1994)
Status: Acquired by Ardea Biosciences (2006) → now AstraZeneca (2012)

Organization Overview

First Clinical Trial
2003
NCT00118781
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

iseganan (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 3)

Pneumonia, Ventilator-Associated (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1